Early research (Phase 1)Study completedNCT01221519
What this trial is testing
A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients
Who this might be right for
Type 2 Diabetes MellitusHigh Blood Sugar
AstraZeneca 20